BioExec Institute
Program Participants
This program is designed for director-level management in the Life Science Industry. Each year, over 50 Life Science directors participate in the full program. In the past four years, the BioExec Institute has brought together more than 225 Participants coming from companies such as:
|
Abgenix
Aemtek
Affymetrix
Alza Corp.
Ambrx
Amgen
Amylin Pharmaceuticals
Arcturus Inc.
Bathgate Capital Partners
Baxter
BD BioScience
Berlex Laboratories
BioAnalytics Marketing
Biomarin Pharmaceutical
BIO
BioScience Forum
Blood Systems Research Institute
Blue Shield of California
Boston Scientific Corporation
British Consulate-General
CardioVascular BioTherapeutics
Chiron Corporation
CHORI
Consulate General of Canada
Cooley Godward LLP
Defense Technology Analysts
Deloitte &
Touche
Development Economic Western Switzerland
EBD Group
EGeen International Corporation
Epitomics
Ernst &
Young
Eureka Therapeutics
Executive Impact Group
Fenwick &
West
Fliesler Meyer LLP
Fortune Capital Partners
Genentech, Inc.
Geraldine Brush Cancer Research Institute
GIRUS Life Sciences
GlobeImmune
Hewlett Packard
Hoag Cancer Center
IMS Health
|
Intel Life Sciences
Invencor
Jazz Pharmaceuticals
Johnson &
Johnson
Kaiser Permanente
Lawrence Livermore National Laboratory
Life Sciences Business Innovation
Light House Capital Partners
Locus Pharmaceuticals
M-Squared
Multispan Inc
Nano Nerve
nanoPharmatix
National Genetics Institute
Nuvelo
Origen Therapeutics
Pain Therapeutics, Inc.
Pharmatech Associates, Inc.
Roche
San Jose BioCenter
San Jose State University
Siemens Medical Solutions
Sonus Pharmaceuticals
Spectrum Pharmaceuticals
Squire, Sanders, &
Dempsey LLP
Stanford Licensing Group
Stanford University
Stanford Medical Center
State of California
Strategic Decisions Group
The Bill &
Melinda Gates Foundation
The Carlock Group
The Institute for OneWorld Health
Two Shea Consulting
U.S. Department of Commerce
UC Berkeley
UC Davis
UC Davis CONNECT
UCSF
Valentis
VaxGen
Wyeth Pharmaceutical
Zila Pharmaceuticals
|
